Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02226042 : Investigating the Mechanisms of Mindfulness-based Cognitive Therapy (MBCT)
PhaseN/A
AgesMin: 18 Years Max: 60 Years
Eligibility
Inclusion Criteria:

Participants with remitted depression (rMDD):

- At least two previous episodes of DSM-IV major depression in adulthood, diagnosed
using the Mini International Neuropsychiatric Interview (M.I.N.I).

- Full or partial remission for at least three months with two depressive episodes
within the last five years.

- A score of less than or equal to 12 on the Montgomery Asberg Depression Rating Scale
(MADRS) mood assessment.

- If on medication, no recent or planned major changes

Healthy volunteers:

- In good psychological health screened with the M.I.N.I

All participants:

- in good physical health (to reduce risk of confounding physical health problems).

- sufficiently fluent in English to ensure valid understanding and completion of the
tasks.

- minimum I.Q level of 80 to ensure sufficient understanding of the neurocognitive
tasks administered.

- colour vision and acuity within normal/corrected to normal limits.

Exclusion criteria:

- Any current mental health diagnosis (DSM-IV diagnosis including current major
depression, bipolar disorder, psychosis, Obsessive Compulsive Disorder (OCD),
substance abuse or dependence, eating disorders)

- Physical health or neurological disorders that might interfere with the
interpretation of the tasks, including a history of significant head injury.

- In addition healthy volunteers will be without a history mental health disorders
(DSM-IV)

- Current or previous experience of mindfulness-based treatments or extensive cognitive
behavioural treatment, or planned participation in psychological treatments during
the key time for the study (between pre and post visits).

- Planned major alteration in drug treatment for depression between pre and post
visits.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02226042      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740